QCI Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,359
| Closed | -$471K | – | 156 |
|
|
2021
Q2 | $471K | Sell |
1,359
-67,439
| -98% | -$20.4M | 0.03% | 94 |
|
|
2021
Q1 | $19.2M | Buy |
68,798
+1,931
| +3% | +$521K | 1.21% | 42 |
|
|
2020
Q4 | $16.4M | Buy |
66,867
+6,224
| +10% | +$1.61M | 1.05% | 48 |
|
|
2020
Q3 | $17.2M | Buy |
60,643
+2,915
| +5% | +$813K | 1.29% | 37 |
|
|
2020
Q2 | $15.4M | Buy |
57,728
+57,720
| +721,500% | +$17.4M | 1.21% | 46 |
|
|
2020
Q1 | $3K | Hold |
8
| – | – | ﹤0.01% | 492 |
|
|
2019
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 544 |
|
|
2019
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 530 |
|
|
2019
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 570 |
|
|
2019
Q1 | $2K | Sell |
8
-253
| -97% | -$79.7K | ﹤0.01% | 554 |
|
|
2018
Q4 | $79K | Hold |
261
| – | – | 0.01% | 202 |
|
|
2018
Q3 | $92K | Hold |
261
| – | – | 0.01% | 196 |
|
|
2018
Q2 | $76K | Hold |
261
| – | – | 0.01% | 203 |
|
|
2018
Q1 | $71K | Hold |
261
| – | – | 0.01% | 218 |
|
|
2017
Q4 | $83K | Hold |
261
| – | – | 0.01% | 196 |
|
|
2017
Q3 | $82K | Buy |
261
+253
| +3,163% | +$74.9K | 0.01% | 174 |
|
|
2017
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 588 |
|
|
2017
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 510 |
|
|
2016
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 478 |
|
|
2016
Q3 | $3K | Hold |
8
| – | – | ﹤0.01% | 453 |
|
|
2016
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 493 |
|
|
2016
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 474 |
|
|
2015
Q4 | $2K | Sell |
8
-100
| -93% | -$28.7K | ﹤0.01% | 466 |
|
|
2015
Q3 | $32K | Hold |
108
| – | – | 0.01% | 237 |
|
|
2015
Q2 | $44K | Hold |
108
| – | – | 0.01% | 195 |
|
|
2015
Q1 | $46K | Buy |
108
+100
| +1,250% | +$39.4K | 0.01% | 192 |
|
|
2014
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 458 |
|
|
2014
Q3 | $3K | Hold |
8
| – | – | ﹤0.01% | 463 |
|
|
2014
Q2 | $3K | Hold |
8
| – | – | ﹤0.01% | 450 |
|
|
2014
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 471 |
|
|
2013
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 478 |
|
|
2013
Q3 | $2K | Sell |
8
-289
| -97% | -$64.7K | ﹤0.01% | 447 |
|
|
2013
Q2 | $64K | Buy |
+297
| New | +$63.5K | 0.01% | 166 |
|
Other funds holding BIIB
QCI Asset Management's BIIB Position: Q3 2021 in Review
QCI Asset Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 1,359 shares — an estimated $471K sold.
QCI Asset Management first reported a position in BIIB in Q2 2013 and held it in 33 quarters. The position peaked at $19.2M in Q1 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.
- QCI Asset Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
- QCI Asset Management sold 1,359 Biogen shares in Q3 2021, an estimated $471K.
- QCI Asset Management first reported a position in Biogen in Q2 2013 and held it in 33 quarters.
- QCI Asset Management's Biogen position peaked at $19.2M in Q1 2021.
- 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.
Based on QCI Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.